Staar Surgical Co. Sets New 1-Year High at $17.00 (STAA)
Shares of Staar Surgical (NASDAQ:STAA) hit a new 52-week high during mid-day trading on Wednesday, AmericanBankingNews.com reports. The stock traded as high as $17.00 and last traded at $16.80, with a volume of 267,237 shares trading hands. The stock had previously closed at $16.23.
Separately, analysts at Canaccord Genuity raised their price target on shares of Staar Surgical from $10.00 to $12.00 in a research note to investors on Thursday, October 31st. They now have a “hold” rating on the stock. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $12.83.
Staar Surgical has a 1-year low of $5.07 and a 1-year high of $17.00. The stock has a 50-day moving average of $14.05 and a 200-day moving average of $12.60. The company’s market cap is $617.3 million.
Staar Surgical (NASDAQ:STAA) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.02. The company had revenue of $17.10 million for the quarter, compared to the consensus estimate of $17.35 million. During the same quarter in the previous year, the company posted $0.04 earnings per share. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. On average, analysts predict that Staar Surgical will post $0.05 earnings per share for the current fiscal year.
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is the maker of lenses used worldwide in corrective or refractive surgery.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.